PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Global X China Biotech Innovation ETF (CHB)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

ETF Info

ISIN

US37954Y2515

CUSIP

37954Y251

Issuer

Global X

Inception Date

Sep 22, 2020

Region

Global ex-U.S. (Broad)

Leveraged

1x

Index Tracked

Solactive China Biotech Innovation Index

Asset Class

Equity

Asset Class Size

Multi-Cap

Asset Class Style

Blend

Expense Ratio

CHB features an expense ratio of 0.67%, falling within the medium range.


Expense ratio chart for CHB: current value at 0.67% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%0.67%

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Popular comparisons:
CHB vs. VOO CHB vs. SPY
Popular comparisons:
CHB vs. VOO CHB vs. SPY

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Global X China Biotech Innovation ETF, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


CHB (Global X China Biotech Innovation ETF)
Benchmark (^GSPC)

Returns By Period


CHB

YTD

N/A

1M

N/A

6M

N/A

1Y

N/A

5Y*

N/A

10Y*

N/A

^GSPC (Benchmark)

YTD

4.22%

1M

2.22%

6M

9.51%

1Y

22.46%

5Y*

12.74%

10Y*

11.29%

*Annualized

Monthly Returns

The table below presents the monthly returns of CHB, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2024-17.10%-18.02%
202310.26%-5.92%-7.16%-0.17%-9.71%-5.65%3.52%-7.49%2.79%6.22%5.23%-4.12%-13.60%
2022-15.01%1.04%-5.27%-14.08%-1.52%16.43%-8.30%-5.59%-14.44%-1.97%18.65%-3.38%-33.29%
20216.22%-1.70%-5.00%15.61%1.57%-1.47%-6.70%-6.41%-1.85%-3.29%1.33%-10.27%-13.52%
20200.66%2.44%-5.12%9.74%7.36%

Risk-Adjusted Performance

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Global X China Biotech Innovation ETF (CHB) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


Sharpe ratio
No data
CHB
^GSPC

There is not enough data available to calculate the Sharpe ratio for Global X China Biotech Innovation ETF. We calculate this metric based on the past 12 months of trading data. Please check back later for updated information.


Rolling 12-month Sharpe Ratio
CHB (Global X China Biotech Innovation ETF)
Benchmark (^GSPC)

Dividends

Dividend History

Global X China Biotech Innovation ETF provided a 0.00% dividend yield over the last twelve months, with an annual payout of $6.72 per share.


0.20%0.25%0.30%0.35%0.40%0.45%$0.00$0.01$0.02$0.03$0.0420222023
Dividends
Dividend Yield
PeriodTTM20232022
Dividend$6.72$0.04$0.02

Dividend yield

0.00%0.48%0.21%

Monthly Dividends

The table displays the monthly dividend distributions for Global X China Biotech Innovation ETF. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2024$0.00$6.72$6.72
2023$0.00$0.00$0.00$0.00$0.00$0.04$0.00$0.00$0.00$0.00$0.00$0.00$0.04
2022$0.02$0.00$0.00$0.00$0.00$0.00$0.00$0.02

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


CHB (Global X China Biotech Innovation ETF)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Global X China Biotech Innovation ETF. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Global X China Biotech Innovation ETF was 66.72%, occurring on Feb 5, 2024. The portfolio has not yet recovered.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-66.72%Feb 17, 2021733Feb 5, 2024
-10.8%Oct 14, 202042Dec 11, 202015Jan 5, 202157
-6.83%Jan 26, 20214Jan 29, 20213Feb 3, 20217
-1.74%Jan 11, 20211Jan 11, 20211Jan 12, 20212
-0.89%Jan 13, 20211Jan 13, 20211Jan 14, 20212

Volatility

Volatility Chart

The current Global X China Biotech Innovation ETF volatility is 4.49%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


CHB (Global X China Biotech Innovation ETF)
Benchmark (^GSPC)
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab